Recent Articles
Nasdaq Quietly Eats a $10M Wrist-Slap for Botching Facebook
May. 30, 2013, 12:51 pm EDT – Nasdaq has agreed to a $10 million settlement with the SEC over the botched Facebook IPO. Now, it just needs time for everyone to forget it. More
Should I Buy AutoZone? 3 Pros, 3 Cons
May. 30, 2013, 11:21 am EDT – Does slow and steady win the race? If you ask AutoZone shareholders, they'd nod to the affirmative. But that's in the past. Can AZO keep it up? More
JetBlue Founder Taking Azul Public
May. 30, 2013, 9:32 am EDT – Azul Brazilian Airlines, founded by JetBlue mastermind David Neeleman, plans to go public in both the U.S. and its home country. More
Should I Buy Williams-Sonoma? 3 Pros, 3 Cons
May. 29, 2013, 1:35 pm EDT – Williams-Sonoma has been aggressive in its multi-brand, multichannel marketing, and to great results. But does that make its stock worth your investment dollar? More
4 Large-Cap Funds for Continued Upside
May. 29, 2013, 11:35 am EDT – If the bulls are right, these four large-cap funds should cash in. Plus, they offer protection in case the bulls happen to be wrong. More
Should I Buy P&G? 3 Pros, 3 Cons
May. 29, 2013, 9:35 am EDT – Procter & Gamble's former CEO is back on board ... but will it be enough for a turnaround? Here are three pros and three cons on the stock. More
Tremor Video Is Serving Up an IPO
May. 29, 2013, 7:00 am EDT – Online video ad operator Tremor Video is bringing its mix of impressive technology and solid business relationships to the public markets. More
Coty Targets a Billion-Dollar IPO
May. 28, 2013, 5:05 pm EDT – Coty announced it will seek an IPO and likely will go public in the next couple weeks, which should help the cosmetics giant on the M&A front. More
Pharma Makes Up This Week’s Small IPO Plate
May. 28, 2013, 11:57 am EDT – Pharma firms Epizyme, Kamada make up the small list of public offerings slated for the holiday-shortened week. More
Pandora Hits a High Note … But Don’t Join In
May. 24, 2013, 11:10 am EDT – Pandora looks in tune with investors today after strong Q1 revenue growth, but you should still be wary of jumping in. Here's why. More
